Boundless Bio, Inc. · NASDAQ:BOLD

Citadel Advisors LLC reported a 6.40% stake in Boundless Bio, Inc. (Schedule 13G)

Event Nov 26, 2025 · Filed Dec 4, 2025

Citadel Advisors LLC reported a 6.40% stake in Boundless Bio, Inc., 1,433,388 shares, as a passive investor on Nov 26, 2025. Filed Dec 4, 2025 (Schedule 13G).

Stake
6.40%
Shares
1,433,388
Intent
Passive
What changed
Crossed above 5%
Filed together
7 holders

The filing in full

HolderStakeShares
Citadel Advisors LLC3.70%830,936
Citadel Advisors Holdings LP3.70%830,936
Citadel GP LLC3.70%830,936
Citadel Securities LLC2.70%602,452
Citadel Securities Group LP2.70%602,452
Citadel Securities GP LLC2.70%602,452
Kenneth Griffin6.40%1,433,388

Source

View original at SEC

Related